Benitec Biopharma (BNTC) EPS (Weighted Average and Diluted) (2021 - 2025)
Benitec Biopharma's (BNTC) quarterly EPS (Weighted Average and Diluted) came in at -$0.26 in Q4 2025, down 30.0% year-on-year from -$0.37 in Q4 2024, and down 18.18% quarter-over-quarter from -$0.22 in Q3 2025.
Benitec Biopharma (BNTC) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Benitec Biopharma has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$0.26 for Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.26, down 30.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.93 (down 29.17% YoY), and the FY2025 annual result was -$1.05, up 13.93% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.26 for Q4 2025 at Benitec Biopharma, down from -$0.22 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.11 in Q2 2024 to a low of -$36.27 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.59 (2021), against an average of -$3.3.
- Across the five-year window, EPS (Weighted Average and Diluted) sank 3940.32% in 2022 and jumped 95.85% in 2024, its largest moves.
- Benitec Biopharma's EPS (Weighted Average and Diluted) stood at -$0.59 in 2021, then slumped by 466.1% to -$3.34 in 2022, then gained by 20.96% to -$2.64 in 2023, then jumped by 92.42% to -$0.2 in 2024, then dropped by 30.0% to -$0.26 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.26 (Q4 2025), -$0.22 (Q3 2025), and -$0.21 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Benitec Biopharma | 488.21 Mn | 488.21 Mn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.22 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -2.64 |
| Sep 30, 2023 | -3.05 |
| Jun 30, 2023 | -2.65 |
| Mar 31, 2023 | -2.67 |
| Dec 31, 2022 | -3.34 |
| Sep 30, 2022 | -7.98 |
| Jun 30, 2022 | -36.27 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.62 |
| Jun 30, 2021 | -0.90 |